ADORA3 and renal fibrosis: The antagonists of the A3 subtype of adenosine receptors have anti-inflammatory properties [38], therefore our aim was to evaluate the inhibitory potential of an ADORA3 antagonist against renal fibrosis and its association with the generation of inflammatory mediators, such as those that are derived from the NLP3 inflammasoma.